The International RBD Study Group

The official account of the Internaitonal RBD Study Group

[The Neuro @TheNeuro_MNI]

Congratulations to Dr. Guy Rouleau, The Neuro's director, who has been elected a Fellow of the American Academy of Neurology (@AANmember). The fellowship is recognition of his valuable contributions to the Academy and to the #neurology community at large.

[Mike A. Nalls @mike_nalls]

Long time in the works, new multi-ancestry Parkinson's meta-GWAS.

12 potential novel risk loci, some analyses of heterogeneity across populations and fine-mapping for 6 known loci.

Shout outs to all the collaborators! https://t.co/9pRS5AoM7d <- open access

[Aligning Science Across Parkinson’s @ASAP_Research]

🚨Calling all Open Science Champions! @TheNeuro_MNI is now accepting applications for the Irv and Helga Cooper Foundation Open Science Prizes. There are multiple prizes available to researchers of all levels. Apply by September 10th!

Learn more: https://t.co/JJLkUm5QXj

[The International RBD Study Group @IRBD_StudyGroup]

@ZivGanOr @AmbraStefani Thank you @HBHLMcGill for sponsoring this panel!

[The International RBD Study Group @IRBD_StudyGroup]

@DarioArnaldi @mcgillu @TheNeuro_MNI @AmbraStefani @OrsoBeatrice Isolated/Idiopathic/Italian RBD Study group

[Milan Nigam @MilanNigam2]

Had a great time at the @IRBD_StudyGroup meeting at @TheNeuro_MNI over the past 3 days. High quality presentations and discussions from current and future legends in the field! Great job @ZivGanOr @ShadyRahayel Ron Postuma and other local organizers on the successful meeting,!

[Dr. Maria Balaet @emmsskyyy]

Thank you to the International RBD study group for the honour of inviting me to present some of my work at @TheNeuro_MNI @mcgillu in Montréal this week. It has been an amazing conference packed with advances, debates and making new friends and I am already looking forward to the next iteration!

[The International RBD Study Group @IRBD_StudyGroup]

Dr. Emmanuel During is talking about actigraphy as a way to diagnose RBD at home. Being able to do that would be a huge step forward!

[The International RBD Study Group @IRBD_StudyGroup]

Having lunch at the very nice relaxation garden of @TheNeuro_MNI. Last stretch of the IRBDSG meeting starting now.

[Ziv Gan-Or @ZivGanOr]

This man is one of my heroes, from my childhood as Marty McFly, and my adulthood as the single most influential person in Parkinson’s disease research and care. Without @realmikefox and the @MichaelJFoxOrg that he established, we would be years behind. Happy belated birthday!

[The International RBD Study Group @IRBD_StudyGroup]

Britanny Dugan, another winner of yhe junior awards for best presentation, is talking about her research on different a-synuclein species in RBD, PD and MSA.

[The International RBD Study Group @IRBD_StudyGroup]

One of our award winners, Russell Luke, presenting his work on a-synuclein spread and pathology with focus on SLD neurons

[The International RBD Study Group @IRBD_StudyGroup]

Excellent talk by Nathan Karpilovsky on a-synuclein spread and uptake.

[The International RBD Study Group @IRBD_StudyGroup]

Kicked off the last day of the IRBDGC meeting with awards for the three top presentations/posters by junior members, given to @Senkkon1, Russell Luke and Brittany Dugan. Congratulations!

[The International RBD Study Group @IRBD_StudyGroup]

Great second day of the IRBDSG meeting yesterday! Lots of great talks, followed by a nice walk through the McGill campus, great music in the st. James church, and a nice dinner to end the night. Looking forward to our last day!

[The International RBD Study Group @IRBD_StudyGroup]

Equity and diversity panel, discussing sex differences, lack of access for diagnosis and care in different populations.

[Coline Zigrand @coline_zigrand]

Congrats to @cece_tremblay for her great presentation at @IRBD_StudyGroup 👏🏼👏🏼

[The International RBD Study Group @IRBD_StudyGroup]

Dr. Ambra Stefani is talking about the usefulness of synuclein assays for clinical trials.

[The International RBD Study Group @IRBD_StudyGroup]

Now Dr. Dario Arnaldi is talking about improtant biomarkers for clinical trials in RBD.

[The International RBD Study Group @IRBD_StudyGroup]

This was followed up by a very interesting discussion on how we will move from preparing towards trials to actual neuroprotective trials in RBD.

[The International RBD Study Group @IRBD_StudyGroup]

We had a great talk by Dr. Elena Antelmi on trial-ready populations, in which she detailed the amazing work done in Italy to have a well-defined, nation-wide trial ready RBD cohort.

[The International RBD Study Group @IRBD_StudyGroup]

Then Dr Emmanuel Mignot, who talked about the current best ways to identify individuals with RBD in the general population.